首页> 外文期刊>Trials >Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized controlled trial
【24h】

Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized controlled trial

机译:败血症性休克严重急性肾损伤患者中肾脏替代治疗时机对死亡率的影响:IDEAL-ICU研究(重症监护病房早期透析与延迟透析):一项随机对照试验的研究方案

获取原文
       

摘要

Background One of the most dreaded complications of septic shock is acute kidney injury. It occurs in around 50% of patients, with a mortality rate of about 60% at 3 months. There is no consensus on the optimal time to initiate renal replacement therapy. Retrospective and observational studies suggest that early implementation of renal replacement therapy could improve the prognosis for these patients. Methods/design This protocol summarizes the rationale and design of a randomized, controlled, multicenter trial investigating the effect of early versus delayed renal replacement therapy in patients with severe acute kidney injury in early septic shock. In total, 864 critically ill adults with septic shock and evidence of acute kidney injury, defined as the failure stage of the RIFLE classification, will be enrolled. The primary outcome is mortality at 90 days. Secondary outcomes include safety, number of days free of mechanical ventilation, number of days free of renal replacement therapy, intensive care length of stay, in-hospital length of stay, quality of life as evaluated by the EQ-5D and renal replacement therapy dependence at hospital discharge. The primary analysis will be intention to treat. Recruitment started in March 2012 and will be completed by March 2015. Discussion This protocol for a randomized controlled study investigating the impact of the timing of renal replacement therapy initiation should provide an answer to a key question for the management of patients with acute kidney injury in the context of septic shock, for whom the mortality rate remains close to 60% despite improved understanding of physiopathology and recent therapeutic advances. Trial registration ClinicalTrials.gov identifier NCT01682590 , registered on 10 September 2012.
机译:背景技术败血症性休克最可怕的并发症之一是急性肾损伤。它发生在约50%的患者中,三个月时的死亡率约为60%。关于开始肾脏替代治疗的最佳时间尚无共识。回顾性研究和观察性研究表明,早期实施肾脏替代治疗可以改善这些患者的预后。方法/设计该方案总结了一项随机,对照,多中心试验的原理和设计,该试验研究了早期败血症性休克严重急性肾损伤患者的早期和延迟肾脏替代治疗的效果。总共将招募864名患有败血症性休克的重症成人,并有急性肾损伤的证据(定义为RIFLE分类的失败阶段)。主要结局是90天时的死亡率。次要结果包括安全性,无机械通气的天数,无肾脏替代疗法的天数,重症监护病房的住院天数,住院时间,EQ-5D评估的生活质量和肾脏替代疗法的依赖性在出院时。主要分析将有意处理。招募工作于2012年3月开始,并将于2015年3月完成。讨论该方案用于一项随机对照研究,研究开始肾脏替代治疗的时间的影响,应为管理急性肾损伤患者的关键问题提供答案。在感染性休克的背景下,尽管人们对生理病理学的了解和最近的治疗进展得到了改善,但死亡率仍然接近60%。试验注册ClinicalTrials.gov标识符NCT01682590,于2012年9月10日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号